Subscription Companies and Genome Databases

What type of companies sell information or access to information and data that is valuable to other companies?

Which type of companies offer solutions based on a common technology or generic tool of other large pharmaceutical or biopharmaceutical companies?

Which type of biotechnology companies support the preclinical, clinical, regulatory, manufacturing, marketing, distribution, and commercialization functions of large pharmaceutical companies?

Which subscription-based companies develop genome databases used to develop medicinal drugs?

What do pharmaceutical companies do with the data from subscription-based companies?

Which service company provides software solutions for biological data analysis?

What is the primary business model utilized by many early genomic discovery companies?

Which type of biotechnology company is most likely to develop genome databases for medicinal purposes based on the text?

What are the three major approaches of protein engineering research mentioned in the text?

Which method of protein engineering involves creating random mutations in the native enzyme?

What does rational design in protein engineering require for designing variants with desired properties?

Which technique involves creating mutations at computationally defined sites in the gene sequence via PCR?

What type of changes are controllable in rational design of proteins?

Which method involves changing the functional group of the side chain in proteins?

In computational protein design, what knowledge is required about the protein of interest?

What are the changes put into practice by site-directed mutagenesis in protein engineering?

What category do techniques used for protein engineering fall into?

What do directed evolution and rational design have in common as stated in the text?